Home Medical Devices Small Animal Imaging Market Size, Trends & Growth | By 2033

Small Animal Imaging Market Size, Share & Trends Analysis Report By Technology (Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Single Photon Emission Computed Tomography (SPECT), Optical Imaging, Photoacoustic Imaging, Others), By Applications (Drug Discovery and Disease Modeling, Preclinical Drug Development, Clinical Trials, Others), By End-User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organization) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRMD56819DR
Author : Debashree Bora

Table Of Content

  1. Executive Summary

    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends

    1. Global Small Animal Imaging Market Introduction
    2. By Technology
      1. Introduction
        1. Technology By Value
      2. Computed Tomography (CT)
        1. By Value
      3. Magnetic Resonance Imaging (MRI)
        1. By Value
      4. Single Photon Emission Computed Tomography (SPECT)
        1. By Value
      5. Optical Imaging
        1. By Value
      6. Photoacoustic Imaging
        1. By Value
      7. Others
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Drug Discovery and Disease Modeling
        1. By Value
      3. Preclinical Drug Development
        1. By Value
      4. Clinical Trials
        1. By Value
      5. Others
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Pharmaceutical and Biotechnology Companies
        1. By Value
      3. Academic and Research Institutes
        1. By Value
      4. Contract Research Organization
        1. By Value
    1. Introduction
    2. By Technology
      1. Introduction
        1. Technology By Value
      2. Computed Tomography (CT)
        1. By Value
      3. Magnetic Resonance Imaging (MRI)
        1. By Value
      4. Single Photon Emission Computed Tomography (SPECT)
        1. By Value
      5. Optical Imaging
        1. By Value
      6. Photoacoustic Imaging
        1. By Value
      7. Others
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Drug Discovery and Disease Modeling
        1. By Value
      3. Preclinical Drug Development
        1. By Value
      4. Clinical Trials
        1. By Value
      5. Others
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Pharmaceutical and Biotechnology Companies
        1. By Value
      3. Academic and Research Institutes
        1. By Value
      4. Contract Research Organization
        1. By Value
    5. U.S.
      1. By Technology
        1. Introduction
          1. Technology By Value
        2. Computed Tomography (CT)
          1. By Value
        3. Magnetic Resonance Imaging (MRI)
          1. By Value
        4. Single Photon Emission Computed Tomography (SPECT)
          1. By Value
        5. Optical Imaging
          1. By Value
        6. Photoacoustic Imaging
          1. By Value
        7. Others
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Drug Discovery and Disease Modeling
          1. By Value
        3. Preclinical Drug Development
          1. By Value
        4. Clinical Trials
          1. By Value
        5. Others
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Pharmaceutical and Biotechnology Companies
          1. By Value
        3. Academic and Research Institutes
          1. By Value
        4. Contract Research Organization
          1. By Value
    6. Canada
    1. Introduction
    2. By Technology
      1. Introduction
        1. Technology By Value
      2. Computed Tomography (CT)
        1. By Value
      3. Magnetic Resonance Imaging (MRI)
        1. By Value
      4. Single Photon Emission Computed Tomography (SPECT)
        1. By Value
      5. Optical Imaging
        1. By Value
      6. Photoacoustic Imaging
        1. By Value
      7. Others
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Drug Discovery and Disease Modeling
        1. By Value
      3. Preclinical Drug Development
        1. By Value
      4. Clinical Trials
        1. By Value
      5. Others
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Pharmaceutical and Biotechnology Companies
        1. By Value
      3. Academic and Research Institutes
        1. By Value
      4. Contract Research Organization
        1. By Value
    5. U.K.
      1. By Technology
        1. Introduction
          1. Technology By Value
        2. Computed Tomography (CT)
          1. By Value
        3. Magnetic Resonance Imaging (MRI)
          1. By Value
        4. Single Photon Emission Computed Tomography (SPECT)
          1. By Value
        5. Optical Imaging
          1. By Value
        6. Photoacoustic Imaging
          1. By Value
        7. Others
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Drug Discovery and Disease Modeling
          1. By Value
        3. Preclinical Drug Development
          1. By Value
        4. Clinical Trials
          1. By Value
        5. Others
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Pharmaceutical and Biotechnology Companies
          1. By Value
        3. Academic and Research Institutes
          1. By Value
        4. Contract Research Organization
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
    1. Introduction
    2. By Technology
      1. Introduction
        1. Technology By Value
      2. Computed Tomography (CT)
        1. By Value
      3. Magnetic Resonance Imaging (MRI)
        1. By Value
      4. Single Photon Emission Computed Tomography (SPECT)
        1. By Value
      5. Optical Imaging
        1. By Value
      6. Photoacoustic Imaging
        1. By Value
      7. Others
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Drug Discovery and Disease Modeling
        1. By Value
      3. Preclinical Drug Development
        1. By Value
      4. Clinical Trials
        1. By Value
      5. Others
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Pharmaceutical and Biotechnology Companies
        1. By Value
      3. Academic and Research Institutes
        1. By Value
      4. Contract Research Organization
        1. By Value
    5. China
      1. By Technology
        1. Introduction
          1. Technology By Value
        2. Computed Tomography (CT)
          1. By Value
        3. Magnetic Resonance Imaging (MRI)
          1. By Value
        4. Single Photon Emission Computed Tomography (SPECT)
          1. By Value
        5. Optical Imaging
          1. By Value
        6. Photoacoustic Imaging
          1. By Value
        7. Others
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Drug Discovery and Disease Modeling
          1. By Value
        3. Preclinical Drug Development
          1. By Value
        4. Clinical Trials
          1. By Value
        5. Others
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Pharmaceutical and Biotechnology Companies
          1. By Value
        3. Academic and Research Institutes
          1. By Value
        4. Contract Research Organization
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Taiwan
    11. South East Asia
    12. Rest of Asia-Pacific
    1. Introduction
    2. By Technology
      1. Introduction
        1. Technology By Value
      2. Computed Tomography (CT)
        1. By Value
      3. Magnetic Resonance Imaging (MRI)
        1. By Value
      4. Single Photon Emission Computed Tomography (SPECT)
        1. By Value
      5. Optical Imaging
        1. By Value
      6. Photoacoustic Imaging
        1. By Value
      7. Others
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Drug Discovery and Disease Modeling
        1. By Value
      3. Preclinical Drug Development
        1. By Value
      4. Clinical Trials
        1. By Value
      5. Others
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Pharmaceutical and Biotechnology Companies
        1. By Value
      3. Academic and Research Institutes
        1. By Value
      4. Contract Research Organization
        1. By Value
    5. UAE
      1. By Technology
        1. Introduction
          1. Technology By Value
        2. Computed Tomography (CT)
          1. By Value
        3. Magnetic Resonance Imaging (MRI)
          1. By Value
        4. Single Photon Emission Computed Tomography (SPECT)
          1. By Value
        5. Optical Imaging
          1. By Value
        6. Photoacoustic Imaging
          1. By Value
        7. Others
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Drug Discovery and Disease Modeling
          1. By Value
        3. Preclinical Drug Development
          1. By Value
        4. Clinical Trials
          1. By Value
        5. Others
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Pharmaceutical and Biotechnology Companies
          1. By Value
        3. Academic and Research Institutes
          1. By Value
        4. Contract Research Organization
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
    1. Introduction
    2. By Technology
      1. Introduction
        1. Technology By Value
      2. Computed Tomography (CT)
        1. By Value
      3. Magnetic Resonance Imaging (MRI)
        1. By Value
      4. Single Photon Emission Computed Tomography (SPECT)
        1. By Value
      5. Optical Imaging
        1. By Value
      6. Photoacoustic Imaging
        1. By Value
      7. Others
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Drug Discovery and Disease Modeling
        1. By Value
      3. Preclinical Drug Development
        1. By Value
      4. Clinical Trials
        1. By Value
      5. Others
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Pharmaceutical and Biotechnology Companies
        1. By Value
      3. Academic and Research Institutes
        1. By Value
      4. Contract Research Organization
        1. By Value
    5. Brazil
      1. By Technology
        1. Introduction
          1. Technology By Value
        2. Computed Tomography (CT)
          1. By Value
        3. Magnetic Resonance Imaging (MRI)
          1. By Value
        4. Single Photon Emission Computed Tomography (SPECT)
          1. By Value
        5. Optical Imaging
          1. By Value
        6. Photoacoustic Imaging
          1. By Value
        7. Others
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Drug Discovery and Disease Modeling
          1. By Value
        3. Preclinical Drug Development
          1. By Value
        4. Clinical Trials
          1. By Value
        5. Others
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Pharmaceutical and Biotechnology Companies
          1. By Value
        3. Academic and Research Institutes
          1. By Value
        4. Contract Research Organization
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
    1. Small Animal Imaging Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Laboratory Corporation of America
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Lonza
    3. WuXi AppTec, Inc.
    4. Eurofins Scientific SE
    5. Intertek Group plc
    6. Medpace Holdings, Inc.
    7. Charles River Laboratories International, Inc.
    8. SGA SA
    9. ICON plc
    10. CROWN bioscience
    11. Miltenyi Biotec GmbH
    12. FUJIFILM Holdings Corporation
    13. MILabs B.V.
    14. LI-COR Biosciences
    15. Mediso Ltd
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer
Straits Research - Access Portal
  • 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
  • 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.



We are featured on :